How many vials of remdesivir did Gilead donate?

Gilead donated over 2,000 vials to Uganda.

Why did Gilead donate the drug?

To support Uganda's response to the Ebola Bundibugyo outbreak.

Is remdesivir approved for Ebola?

No, it is not fully approved but has shown potential in preclinical studies.

Gilead Donates 2,000+ Vials of Remdesivir to Uganda for Ebola

Gilead Sciences donated over 2,000 vials of its antiviral drug remdesivir to Uganda to combat the Ebola Bundibugyo outbreak. The donation aims to support emergency health efforts and underscores Gilead's commitment to global health.

June 17, 2026

2 min read

Source: Insider Monkey

Key Numbers

vials

2,000+

On June 12, 2026, Gilead Sciences, Inc. (NASDAQ:GILD) announced a donation of more than 2,000 vials of its intravenous antiviral therapy, remdesivir, to the Republic of Uganda. The donation is intended to support response efforts for the ongoing outbreak of Ebola Bundibugyo virus.

Details

The donation comprises over 2,000 vials of remdesivir, an antiviral drug commonly used for COVID-19 but also showing potential against Ebola viruses in preclinical studies. The drugs will be distributed through the Ugandan Ministry of Health.

Context

The donation comes as Uganda faces an outbreak of the Bundibugyo strain of Ebola, which is distinct from the more common Zaire strain. Remdesivir has not yet received full approval for Ebola treatment, but its use in emergency settings may provide a therapeutic option.

What It Means for Investors

Gilead's donation enhances its reputation as a socially responsible company but does not directly impact revenue or earnings. Investors may view it as a positive brand move, but it is not a stock driver.

Frequently Asked Questions

Remdesivir is an intravenous antiviral drug used to treat COVID-19 and being studied for other viruses like Ebola.

Found this useful? Share it

This article was rewritten in Wrqti's editorial style based on information from the original source above. Content is informational only — not investment advice.